Orgenesis Granted FDA Orphan Drug Designation for Autologous Insulin Producing Cells in the Treatment of Severe Hypoglycemia-Prone Diabetes Resulting from Total Pancreatectomy
Stock Information for Orgenesis Inc.
Loading
Please wait while we load your information from QuoteMedia.